ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.539,61
-0,09%
S&P 500
5.307,01
0,00%
US Dollar vs BRL
5,1337
-0,37%
Bitcoin
69.268,11
0,24%
Brent Oil
82,555
1,26%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Arno Therapeutics Inc (CE) (ARNI)

  7. Arno Therapeutics Inc (CE) (ARNI) Notícias

ARNI

Arno Therapeutics (CE) (ARNI)

Arno Therapeutics Inc (CE)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:ARNI
DataHoraFonteTítuloCódigoCompanhia
03/01/201820:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARNIArno Therapeutics Inc (CE)
03/04/201707:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201718:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201718:00Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201715:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201715:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201719:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201719:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ARNIArno Therapeutics Inc (CE)
18/11/201619:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARNIArno Therapeutics Inc (CE)
14/11/201619:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201618:42Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201608:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARNIArno Therapeutics Inc (CE)
12/10/201616:05Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARNIArno Therapeutics Inc (CE)
08/09/201617:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/08/201616:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201610:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201609:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARNIArno Therapeutics Inc (CE)
15/04/201611:53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201616:40Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/03/201617:06Edgar (US Regulatory)Annual Report (10-k)USOTC:ARNIArno Therapeutics Inc (CE)
24/03/201617:43Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201519:30Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201519:05Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
18/07/201417:30GlobeNewswire Inc.Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...USOTC:ARNIArno Therapeutics Inc (CE)
29/05/201417:30GlobeNewswire Inc.Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare ConferenceUSOTC:ARNIArno Therapeutics Inc (CE)
15/05/201417:40GlobeNewswire Inc.Arno Therapeutics Reports First Quarter 2014 Financial and Business UpdateUSOTC:ARNIArno Therapeutics Inc (CE)
14/05/201418:00GlobeNewswire Inc.Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...USOTC:ARNIArno Therapeutics Inc (CE)
05/05/201409:30GlobeNewswire Inc.Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual MeetingUSOTC:ARNIArno Therapeutics Inc (CE)
07/04/201411:42GlobeNewswire Inc.Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201410:10GlobeNewswire Inc.Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational MilestonesUSOTC:ARNIArno Therapeutics Inc (CE)
 Apresentando as notícias mais relevantes sobre:USOTC:ARNI

Seu Histórico Recente

COIN
PVNUST
PROVISIONAL
BIT
F10068
Vontobel Financial Produ...
USOTC
OEZVF
Verbund (PK)
BIT
P1YFY0
NLBNPIT1YFY0 20991231 23...
LSE
51TR
Senegal.re 37 S
USOTC
XASJF
Xtrackers MSCI A A Ex J ... (GM)
BITMOT
2737256
Lottomaticas Eur3m+4% De...
BITMOT
853448
Brera Tv Dc72 Abs Sts Am...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados